Payment overview · 2025
General Payments
$60.86
2 reported records · 2 companies
Healthcare provider profile · identity verified
Robert E Burke, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HORSEHEADS, NY · NPI 1144378837
Verified facts
What the public records show
CMS Open Payments records show Robert E Burke, M.D. received $60.86 in general payments during 2025 across 2 reported records.
Exact Sciences Corporation accounted for 72.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $44.33 | 72.8% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.53 | 27.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $60.86 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $44.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
40 | 12 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 595 | 164 |
| Amlodipine Besylate | Amlodipine Besylate | 450 | 129 |
| Levothyroxine Sodium | Levothyroxine Sodium | 385 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 347 | 106 |
| Omeprazole | Omeprazole | 341 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 331 | 82 |
| Losartan Potassium | Losartan Potassium | 278 | 74 |
| Lisinopril | Lisinopril | 257 | 72 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 231 | 69 |
| Gabapentin | Gabapentin | 220 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 211 | 64 |
| Potassium Chloride | Potassium Chloride | 194 | 66 |
| Metformin Hcl | Metformin Hcl | 180 | 58 |
| Eliquis | Apixaban | 176 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 161 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 154 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 39 |
| Montelukast Sodium | Montelukast Sodium | 150 | 39 |
| Alprazolam | Alprazolam | 147 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 147 | 85 |
| Sertraline Hcl | Sertraline Hcl | 139 | 34 |
| Furosemide | Furosemide | 126 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 32 |
| Spironolactone | Spironolactone | 122 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 120 | 22 |
| Trazodone Hcl | Trazodone Hcl | 113 | 34 |
| Simvastatin | Simvastatin | 111 | 30 |
| Ezetimibe | Ezetimibe | 104 | 32 |
| Allopurinol | Allopurinol | 103 | 32 |
| Famotidine | Famotidine | 101 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 100 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 97 | 18 |
| Meloxicam | Meloxicam | 93 | 35 |
| Glimepiride | Glimepiride | 89 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 89 | 23 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 86 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 17 |
| Bupropion Xl | Bupropion Hcl | 80 | 21 |
| Tramadol Hcl | Tramadol Hcl | 77 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 74 | 21 |
| Torsemide | Torsemide | 73 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 70 | 56 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 69 | 68 |
| Donepezil Hcl | Donepezil Hcl | 67 | 17 |
| Pregabalin | Pregabalin | 66 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 63 | 58 |
| Carvedilol | Carvedilol | 63 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | 16 |
| Dutasteride | Dutasteride | 61 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | 16 |
| Ramipril | Ramipril | 58 | 16 |
| Terazosin Hcl | Terazosin Hcl | 58 | 12 |
| Jardiance | Empagliflozin | 57 | 15 |
| Prednisone | Prednisone | 57 | 44 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 56 | 15 |
| Buspirone Hcl | Buspirone Hcl | 53 | 17 |
| Finasteride | Finasteride | 53 | 12 |
| Azithromycin | Azithromycin | 50 | 45 |
| Celecoxib | Celecoxib | 49 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 49 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 48 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 46 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 46 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 12 |
| Baclofen | Baclofen | 45 | suppressed |
| Lansoprazole | Lansoprazole | 45 | suppressed |
| Clonazepam | Clonazepam | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 13 |
| Enalapril Maleate | Enalapril Maleate | 44 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Januvia | Sitagliptin Phosphate | 42 | 11 |
| Atenolol | Atenolol | 41 | 12 |
| Topiramate | Topiramate | 41 | suppressed |
| Methocarbamol | Methocarbamol | 40 | 19 |
| Ozempic | Semaglutide | 40 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 40 | 12 |
| Warfarin Sodium | Warfarin Sodium | 39 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | 12 |
| Alendronate Sodium | Alendronate Sodium | 37 | suppressed |
| Amoxicillin | Amoxicillin | 37 | 24 |
| Glipizide | Glipizide | 37 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 25 |
| Valsartan | Valsartan | 37 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Fenofibrate | Fenofibrate | 35 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 17 |
| Irbesartan | Irbesartan | 35 | suppressed |
| Mupirocin | Mupirocin | 35 | 24 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 13 |
| Sucralfate | Sucralfate | 34 | 11 |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Lovastatin | Lovastatin | 33 | 11 |
| Linzess | Linaclotide | 32 | suppressed |
| Acyclovir | Acyclovir | 31 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | 14 |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 30 | suppressed |
| Temazepam | Temazepam | 29 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 28 | 12 |
| Digoxin | Digoxin | 28 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Cefdinir | Cefdinir | 27 | 23 |
| Trulicity | Dulaglutide | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 17 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Tradjenta | Linagliptin | 21 | suppressed |
| Verapamil Sr | Verapamil Hcl | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 17 |
| Sildenafil Citrate | Sildenafil Citrate | 19 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 16 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 14 |
| Rybelsus | Semaglutide | 18 | suppressed |
| Armour Thyroid | Thyroid,pork | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 14 |
| Cilostazol | Cilostazol | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Ursodiol | Ursodiol | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 13 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Nabumetone | Nabumetone | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Budesonide Dr | Budesonide | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 12 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $60.86 · 2 records | Exact Sciences Corporation | Cologuard Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error